Carlos Pérez‐Ruixo

Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression

Carlos Pérez‐Ruixo, Stefaan Rossenu, Peter Zannikos et al. · Clinical Pharmacokinetics · 2020 · 69 citations

Psychoactive Drug, Healthy Subjects, Psychiatry +11

Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 study

Hiroji Uemura, Takefumi Satoh, Hideyasu Tsumura et al. · Prostate International · 2020 · 24 citations · Full text

Efficacy and Safety Exposure–Response Relationships of Apalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer

Carlos Pérez‐Ruixo, Oliver Ackaert, Danièle Ouellet et al. · Clinical Cancer Research · 2020 · 23 citations

Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects

Carlos Pérez‐Ruixo, Jonás Samuel Pérez‐Blanco, Caly Chien et al. · Clinical Pharmacokinetics · 2019 · 22 citations

Urology, Oncology, Medicine +7

Population pharmacokinetics of PM00104 (Zalypsis®) in cancer patients

Carlos Pérez‐Ruixo, Belén Valenzuela, Carlos Fernández Teruel et al. · Cancer Chemotherapy and Pharmacology · 2011 · 18 citations

Medicine, Pharmacology, Pharmacotherapy +4